521092-35-3

Upstream product

• 21983-72-2 3,3-dimethoxy-butan-2-one 
• 14527-26-5 2-methylisothiourea sulphate 
• 106157-94-2 1-(dimethylamino)-4,4-dimethoxypent-1-en-3-one 
• 74-88-4 methyl iodide 
• 905440-51-9 1,4,4-trimethoxy-pent-1-en-3-one 

Downstream Products

• 496863-48-0 1-(2-methylsulfanyl-pyrimidin-4-yl)-ethanone 
• 521092-07-9 1-(4-fluorophenyl)-5-(2-methylsulfanylpyrimidin-4-yl)-4-imidazolin-2-one 
• 521092-64-8 C₁₇H₂₁N₃O₄S 
• 521091-13-4 C₁₆H₁₆FN₅O 
• 521087-88-7 1-(2-cyanobenzyl)-3-(4-fluorophenyl)-4-(2-isopropoxypyrimidin-4-yl)-4-imidazolin-2-one 
• 521092-46-6 1-(2-methylsulfanylpyrimidin-4-yl)ethanoneoxime tosylate 
• 521092-16-0 1-(4-fluorophenyl)-5-(2-methylsulfinylpyrimidin-4-yl)-4-imidazolin-2-one 
• 521092-71-7 C₁₆H₁₉FN₄O₃S 
• 521092-72-8 C₁₆H₁₉FN₄O₅S 
• 521092-13-7 1-(2-cyanobenzyl)-3-(4-fluorophenyl)-4-(2-methylsulfinylpyrimidin-4-yl)-4-imidazolin-2-one 

Relevant academic research and scientific papers

PROCESS FOR PRODUCTION OF 4-ACETYLPYRIMIDINES AND CRYSTALS THEREOF

Compound (II) is reacted with formate in the presence of an alkali metal alkoxide and the like to give compound (III); then this is reacted with compound (IVa) or compound (IVb) to give compound (V); then this is reacted with compound (VI) to give compoun

4-IMIDAZOLIN-2-ONE COMPOUNDS

The present invention relates to a compound of the formula [I] : ???wherein G1 is an alkyl which,may be substituted by a halogen atom or an alkoxy, or a group of the formula: ??????wherein ring B is benzene ring which may be substituted, etc.,